PL425238A1 - Application of 2'-hydroxy-4-ethylchalcone - Google Patents
Application of 2'-hydroxy-4-ethylchalconeInfo
- Publication number
- PL425238A1 PL425238A1 PL425238A PL42523818A PL425238A1 PL 425238 A1 PL425238 A1 PL 425238A1 PL 425238 A PL425238 A PL 425238A PL 42523818 A PL42523818 A PL 42523818A PL 425238 A1 PL425238 A1 PL 425238A1
- Authority
- PL
- Poland
- Prior art keywords
- ethylchalcone
- hydroxy
- application
- prevention
- treatment
- Prior art date
Links
Abstract
Przedmiotem zgłoszenia jest zastosowanie 2'-hydroksy-4-etylochalkonu do wytwarzania leku i/lub jako składnika produktów leczniczych do leczenia i zapobiegania kamicy nerkowej, kamicy moczowodu oraz kamienia w obrębie dolnych dróg moczowych, jak również zapalenia pęcherza moczowego oraz do wytwarzania suplementów diety, środków żywieniowych lub jako składnika żywności funkcjonalnej, stosowanych wspomagająco w leczeniu i w profilaktyce tych chorób.The subject of the application is the use of 2'-hydroxy-4-ethylchalcone in the manufacture of a drug and / or as a component of medicinal products for the treatment and prevention of nephrolithiasis, ureterolithiasis and calculus in the lower urinary tract, as well as cystitis and for the production of dietary supplements, nutritional agents or as an ingredient of functional foods, used to support the treatment and prevention of these diseases.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL425238(22)20180416A PL238124B1 (en) | 2018-04-16 | 2018-04-16 | Application of 2'-hydroxy-4-ethylchalcone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL425238(22)20180416A PL238124B1 (en) | 2018-04-16 | 2018-04-16 | Application of 2'-hydroxy-4-ethylchalcone |
Publications (2)
Publication Number | Publication Date |
---|---|
PL425238A1 true PL425238A1 (en) | 2019-10-21 |
PL238124B1 PL238124B1 (en) | 2021-07-05 |
Family
ID=68238665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL425238(22)20180416A PL238124B1 (en) | 2018-04-16 | 2018-04-16 | Application of 2'-hydroxy-4-ethylchalcone |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL238124B1 (en) |
-
2018
- 2018-04-16 PL PL425238(22)20180416A patent/PL238124B1/en unknown
Non-Patent Citations (4)
Title |
---|
BASAR N., COMPARATIVE CYTOTOXICITY OF GLYCYRRHIZA GLABRA ROOTS FRAM DIFFERENT GEOGRAPHICAL ORIGINS AGAINST IMMORTAL HUMAN KERATINOCYTE HACAT LUNG ADENOCARCINOMA A549 AND LIVER CARCINOMA HEPG2 CELIS, 2015 * |
D.K. MAHAPATRA S. K. BHARTI V. ASATI, CHALCONE SCAFFOLDS AS ANTI-INFECTIVE AGENTS: STRUCTURAL AND MOLECULAR TARGET PERSPECTIVES, 2015 * |
MDE L. A1VAREZ V. E. ZARELLI N. B. PAPPANO N. B. DEBATTISTA, BACTERIOSTATIC ACTION OF SYNTHETIC POLYHYDRAXYLATED CHALCONES AGAINST ESCHERICHIA COLI, 2004 * |
Z. NOWAKOWSKA, A REVIEW OF ANTI-INFECTIVE AND ANTI-INFLAMMATORY CHALCONES, 2007 * |
Also Published As
Publication number | Publication date |
---|---|
PL238124B1 (en) | 2021-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ745678A (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
BR112018014545A2 (en) | probiotics for use as anti-inflammatory agents in the oral cavity | |
AR106644A1 (en) | NUTRITIONAL SYNERGISTIC COMPOSITIONS AND USES OF THE SAME | |
BR102013003570A8 (en) | PLATELET-RICH PLASMA COMPOSITIONS | |
EP3318251A3 (en) | Composition for preventing or treating obesity or lipid-related metabolic disease | |
MD3359146T2 (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
BR112018076800A2 (en) | guanidine derivative, medicament, protein 1 inhibitor of mucosal-associated lymphoid tissue lymphoma translocation, and therapeutic or prophylactic agent. | |
MY195760A (en) | Use of IDHP in Preparation of Drug or Health Product for Prevention and Treatment of Coronary Atherosclerosis Disease | |
MX2007004104A (en) | Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress. | |
PL425239A1 (en) | Application of 2'-hydroxy-4-methylchalcone | |
PL425238A1 (en) | Application of 2'-hydroxy-4-ethylchalcone | |
PL425240A1 (en) | Application of 7-aminoflavone | |
PL425242A1 (en) | Application of 3'-amino-4-carboxychalcone | |
PL425241A1 (en) | Application of 2'-hydroxychalcone | |
PL425235A1 (en) | Application of isoxanthohumol | |
WO2019040459A3 (en) | Composition and nutritional supplement made therefrom | |
EP4234035A3 (en) | A pharmaceutical combination for the treatment of a cancer | |
SG11201806628UA (en) | New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof | |
EA202090728A1 (en) | APPLICATION OF NOR-URSODEOXYCHOLIC ACID TO REDUCE LIVER FAT | |
PL423329A1 (en) | Application of Kamchatka berry Lonicera caerulea L. var. Kamtschatica or its tissue or the products thereof, preferably the fruit extract | |
ZA202104321B (en) | Aqueous paediatric retinol formulations | |
PL421363A1 (en) | Application of a cornel-tree Cornus mas L. or its tissue or the products thereof, preferably fruit extract | |
PL429745A1 (en) | Functional protein agglomerate | |
PL414927A1 (en) | Chewing gum that improves one's well-being (B<sub>12</sub>, D<sub>3</sub>, folic acid) |